Related references
Note: Only part of the references are listed.Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells
Mark N. Lee et al.
SCIENCE IMMUNOLOGY (2021)
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
Sylvia Hartmann et al.
CANCERS (2021)
Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapy
Mohamed Shanavas et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
Tomohiro Aoki et al.
CANCER DISCOVERY (2020)
The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma
Joji Nagasaki et al.
BLOOD ADVANCES (2020)
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1
Sarah Reinke et al.
BLOOD (2020)
Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer
Livius Penter et al.
ONCOIMMUNOLOGY (2019)
Clonal replacement of tumor-specific T cells following PD-1 blockade
Kathryn E. Yost et al.
NATURE MEDICINE (2019)
T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes
Tomasz Kula et al.
CELL (2019)
FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells
Livius Penter et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity throughout Life
Michelle Miron et al.
JOURNAL OF IMMUNOLOGY (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
The role of T cells in the microenvironment of Hodgkin lymphoma
Frederik Wein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Alexander M. Lesokhin et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
Margaretha G. M. Roemer et al.
CANCER IMMUNOLOGY RESEARCH (2016)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Deconstructing the Peptide-MHC Specificity of T Cell Recognition
Michael E. Birnbaum et al.
CELL (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Linking T-cell receptor sequence to functional phenotype at the single-cell level
Arnold Han et al.
NATURE BIOTECHNOLOGY (2014)
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells
Paul Greaves et al.
BLOOD (2013)
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green et al.
BLOOD (2010)
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients
Maher K. Gandhi et al.
BLOOD (2006)
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
NA Marshall et al.
BLOOD (2004)
Share Paper
